These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 5008310)

  • 1. A microassay for cytotoxic antibody using 125 I-iododeoxyuridine-labelled target cells.
    Cohen AM; Millar RC; Ketcham AS
    Transplantation; 1972 Jan; 13(1):57-60. PubMed ID: 5008310
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitation of cytotoxic antitumor antibody in vitro: a microassay with 125I-iododeoxyuridine as a tumor cell label.
    Fritze D; Kern DH; Pilch YH
    J Natl Cancer Inst; 1974 Nov; 53(5):1403-7. PubMed ID: 4431057
    [No Abstract]   [Full Text] [Related]  

  • 3. A microassay for the guantitation of cytotoxic antitumor antibody: use of 125 I-iododeoxyuridine as a tumor cell label.
    LeMevel BP; Wells SA
    J Natl Cancer Inst; 1973 Mar; 50(3):803-6. PubMed ID: 4708159
    [No Abstract]   [Full Text] [Related]  

  • 4. Study of a microassay for the quantitation of cytotoxic antitumor antibody, using 125I-iododeoxyuridine as a target cell label; detection of a static effect on cell DNA synthesis.
    Le Mevel BP; Wells SA
    Biomedicine; 1976 Dec; 24(6):434-42. PubMed ID: 1022316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of exogenous thymidine concentration on the incorporation of labelled thymidine and iododeoxyuridine, and on growth of JU56 cells in vitro.
    Moore RC; Martin RF; Hodgson GS
    Aust J Exp Biol Med Sci; 1973 Apr; 51(2):169-79. PubMed ID: 4736769
    [No Abstract]   [Full Text] [Related]  

  • 6. Cell-mediated cytotoxicity: an assay using 125 I-iododeoxyuridine-labeled target cells.
    Cohen AM; Burdick JF; Ketcham AS
    J Immunol; 1971 Sep; 107(3):895-8. PubMed ID: 5572095
    [No Abstract]   [Full Text] [Related]  

  • 7. Two methods for detecting different aspects of the immune response to a xenograft in mice.
    Newlands ES
    Immunology; 1974 Oct; 27(4):543-52. PubMed ID: 4611905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of cell-mediated cytotoxic reactivity against tumor associated antigens with 125I-iododeoxyuridine labeled target cells.
    Oldham RK; Herberman RB
    J Immunol; 1973 Dec; 111(6):862-71. PubMed ID: 4750872
    [No Abstract]   [Full Text] [Related]  

  • 9. Humoral immunostimulation. II. Increased nucleoside incorporation, DNA synthesis, and cell growth in L cells treated with anti-L cell antibody.
    Shearer WT; Philpott GW; Parker CW
    Cell Immunol; 1975 Jun; 17(2):447-62. PubMed ID: 1125994
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of a cell-mediated cytotoxicity assay utilizing 125 iododeoxyuridine-labeled tissue-culture target cells.
    Oldham RK; Siwarski D; McCoy JL; Plata EJ; Herberman RB
    Natl Cancer Inst Monogr; 1973 Jun; 37():49-58. PubMed ID: 4268324
    [No Abstract]   [Full Text] [Related]  

  • 11. A microassay for humoral cytotoxicity demonstrating sublethal effects of antibody.
    Cleveland PH; McKhann CF; Johnson K; Nelson S
    Int J Cancer; 1974 Sep; 14(3):417-26. PubMed ID: 4459274
    [No Abstract]   [Full Text] [Related]  

  • 12. An evaluation of a modified fluorochromatic test for the detection of cytotoxic antibodies.
    Elves MW
    J Immunol Methods; 1973 Jan; 2(2):129-36. PubMed ID: 4807803
    [No Abstract]   [Full Text] [Related]  

  • 13. A terminal-labelling microcytotoxicity assay with 125I-iododeoxyuridine as a label for target cells.
    Stirrat GM
    J Immunol Methods; 1976; 12(3-4):201-18. PubMed ID: 987115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxic effect of antisera on 51Cr-labelled monolayers of skeletal muscle.
    Dawkins RL; Loewi G
    J Pathol; 1973 May; 110(1):67-74. PubMed ID: 4723538
    [No Abstract]   [Full Text] [Related]  

  • 15. Incorporation of 125-I-iododeoxyuridine into target cells as an assay for cell immunity.
    Fish F; Yaakubovicz M; Witz IP
    J Natl Cancer Inst; 1974 Dec; 53(6):1743-7. PubMed ID: 4436870
    [No Abstract]   [Full Text] [Related]  

  • 16. Biology of the mycobacterioses. The measurement of antibodies.
    Farr RS; Minden P
    Ann N Y Acad Sci; 1968 Sep; 154(1):107-14. PubMed ID: 4909582
    [No Abstract]   [Full Text] [Related]  

  • 17. Evaluation of the cell-mediated immune response to murine sarcoma virus by (125I)iododeoxyuridine assay and comparison with chromium 51 and microcytotoxicity assays.
    Fossati G; Holden HT; Herberman RB
    Cancer Res; 1975 Sep; 35(9):2600-8. PubMed ID: 167966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reutilization of thymidine and iododeoxyuridine by mouse mammary carcinoma strain MTG-B 1 .
    Clifton KH; Cooper JM
    Proc Soc Exp Biol Med; 1973 Apr; 142(4):1145-51. PubMed ID: 4694816
    [No Abstract]   [Full Text] [Related]  

  • 19. An evaluation of 125I-iododeoxyuridine as a cellular label for in vitro assays: kinetics of incorporation and toxicity.
    Le Mevel BP; Oldham RK; Wells SA; Herberman RB
    J Natl Cancer Inst; 1973 Nov; 51(5):1551-8. PubMed ID: 4797027
    [No Abstract]   [Full Text] [Related]  

  • 20. A sensitive in vitro microassay for detecting antibody-dependent cellular cytotoxicity. Possible role in monitoring lymphocyte function.
    Zighelboim J; Gale RP; Ossorio RC; Fahey JL
    Transplantation; 1974 Jul; 18(1):27-30. PubMed ID: 4546037
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.